Strand Therapeutics
Sanjana Manja is a Principal Associate Scientist at Strand Therapeutics since May 2023, with previous experience as a Senior Research Associate at SQZ Biotechnologies, where contributions included IND-enabling studies for a personalized cancer vaccine and supporting FDA submissions. Sanjana also served as a Research Associate at The University of Texas Medical Branch, specializing in protein expression and rodent handling. Educational qualifications include a Master's degree in Biotechnology from the University of Central Florida and a Bachelor's degree from B. M. S. College of Engineering. Throughout professional and academic roles, expertise has been demonstrated in immunological techniques, data analysis, and the development of novel cell-based therapies.
This person is not in any teams
Strand Therapeutics
3 followers
Strand was started by biological engineers working together at MIT. Building on the idea of creating smart therapies that are capable of making sophisticated decisions, they sought to apply the concept of the emerging field of mRNA therapeutics.